Jeremy has made over 2 trades of the Endologix stock since 2015, according to the Form 4 filled with the SEC. Most recently Jeremy bought 8,200 units of ELGX stock worth 2,952$ on 2 September 2015.
The largest trade Jeremy's ever made was buying 18,000 units of Endologix stock on 20 August 2015 worth over 7,020$. On average, Jeremy trades about 2,382 units every 1 days since 2015. As of 2 September 2015 Jeremy still owns at least 26,200 units of Endologix stock.
You can see the complete history of Jeremy Hayden stock trades at the bottom of the page.
Jeremy's mailing address filed with the SEC is 2, Musick, Irvine Spectrum, Irvine, Orange, California, 92618, United States of America.
Over the last 22 years, insiders at Endologix have traded over 72,068,611$ worth of Endologix stock and bought 306,824 units worth 2,023,811$ . The most active insiders traders include International, L.P. Elliott、Associates, L.P. Elliott、Capital Management Lp Camber. On average, Endologix executives and independent directors trade stock every 27 days with the average trade being worth of 13,088$. The most recent stock trade was executed by Dan Lemaitre on 4 September 2020, trading 51,844 units of ELGX stock currently worth 2,592$.
Endologix, Inc. engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA.
Endologix executives and other stock owners filed with the SEC include: